XOMAP Q1 2017 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$309M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$260,000-93.4% YoY

Gross Profit

-$4M-1435.8% margin

Operating Income

-$11M-4200.0% margin

Net Income

-$11M-4121.2% margin

EPS (Diluted)

$-0.95

QoQ Revenue Growth

-50.4%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$23M

Total Liabilities

$54M

Stockholders' Equity

-$31M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$260,000	$4M	-93.4%
Gross Profit	-$4M	-$10M	+61.3%
Operating Income	-$11M	-$14M	+21.9%
Net Income	-$11M	-$8M	-28.1%